Errors in Table

The Original Investigation titled, “Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance Database,”¹ published March 23, 2022, included erroneous data points in Table 1 for the patients in the psoriasis cohort who were administered prednisone during follow-up. Table 1 has been updated to include the correct data points.